Jefferies Group's KNSA Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 5,000 shares of Kiniksa Pharmaceuticals International, plc (KNSA) worth $240,750, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Jefferies Group has maintained this position in KNSA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2024, adding 31,800 shares. Largest reduction occurred in Q1 2025, reducing 112,400 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Kiniksa Pharmaceuticals International plc (KNSA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kiniksa Pharmaceuticals International plc (KNSA) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +5,000 | New Buy | 5,000 | $48.15 |
| Q1 2025 | -112,400 | Sold Out | 0 | $0.00 |
| Q4 2024 | +31,800 | Add 39.45% | 112,400 | $19.78 |
| Q3 2024 | +80,600 | New Buy | 80,600 | $24.99 |
Jefferies Group's Kiniksa Pharmaceuticals International plc Investment FAQs
Jefferies Group first purchased Kiniksa Pharmaceuticals International, plc (KNSA) in Q3 2024, acquiring 80,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Kiniksa Pharmaceuticals International, plc (KNSA) for 4 quarters since Q3 2024.
Jefferies Group's largest addition to Kiniksa Pharmaceuticals International, plc (KNSA) was in Q3 2024, adding 80,600 shares worth $2.01 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 5,000 shares of Kiniksa Pharmaceuticals International, plc (KNSA), valued at approximately $240,750.
As of the Q1 2026 filing, Kiniksa Pharmaceuticals International, plc (KNSA) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Kiniksa Pharmaceuticals International, plc (KNSA) was 112,400 shares, as reported at the end of Q4 2024.